[Federal Register Volume 67, Number 178 (Friday, September 13, 2002)]
[Notices]
[Page 58066]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-23333]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Prospective Grant of Exclusive License: P2X7: Receptor 
Antagonists; Correction

    A notice published in the August 29, 2002 Federal Register--
announcing the prospective grant of an exclusive license for the use of 
P2X7 receptor antagonists (67 FR 55415)--incorrectly listed 
the receipt date for comments/license applications as ``October 28, 
2002'' under the DATES section. This notice serves to correct the date 
to reflect a 90-day review period rather than a 60-day review period. 
To allow interested parties adequate time to respond, NIH is publishing 
this notice to amend the DATES: section to read: ``Only written 
comments and/or applications for a license which are received by the 
NIH Office of Technology Transfer on or before December 12, 2002, will 
be considered.''

    Dated: September 3, 2002.
Jack Spiegel,
Director, Division of Technology Development and Transfer, Office of 
Technology Transfer.
[FR Doc. 02-23333 Filed 9-12-02; 8:45 am]
BILLING CODE 4140-01-P